Cargando…
Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease—Possible Causes and Future Considerations
Cardiovascular disease (CVD) that includes myocardial infarction and stroke, is the leading cause of mortality worldwide. Atherosclerosis, the primary underlying cause of CVD, can be controlled by pharmacological and dietary interventions, including n-3 polyunsaturated fatty acid (PUFA) supplementat...
Autores principales: | Michaeloudes, Charalambos, Christodoulides, Stephanos, Christodoulou, Panayiota, Kyriakou, Theodora-Christina, Patrikios, Ioannis, Stephanou, Anastasis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675410/ https://www.ncbi.nlm.nih.gov/pubmed/38004225 http://dx.doi.org/10.3390/nu15224830 |
Ejemplares similares
-
DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases
por: Kousparou, Christina, et al.
Publicado: (2023) -
10th International Multithematic Scientific Bio-Medical Congress (IMBMC), Nicosia, Cyprus, 2022
por: Christodoulou, Panayiota, et al.
Publicado: (2023) -
Amygdalin as a chemoprotective agent in co-treatment with cisplatin
por: Christodoulou, Panayiota, et al.
Publicado: (2022) -
Omega-3 Long-Chain Polyunsaturated Fatty Acids, EPA and DHA: Bridging the Gap between Supply and Demand
por: Tocher, Douglas R, et al.
Publicado: (2019) -
7th International Multithematic Scientific Bio-Medical Congress (IMBMC), Nicosia, Cyprus, 2019
por: Christodoulou, Panayiota, et al.
Publicado: (2020)